FDA-TRACK Releases FY 2021 and FY 2020 Data from PDUFA, BsUFA, ADUFA and AGDUFA

The FDA utilizes the User Fee Programs to assess and collect fees to fulfill its mission of protecting the public health and accelerating in

Receive this email as a forward? Subscribe to CDER SBIA industry updates. FDA | CDER | Small Business and Industry Assistance INDUSTRY NEWS . FDA-TRACK Releases FY 2021 and FY 2020 Data from PDUFA, BsUFA, ADUFA and AGDUFA   FDA-TRACK is releasing the latest annual User Fee Program data for animal and human drug and biosimilar products. Final review performance results for FY 2020 and preliminary performance results for FY 2021 are now available. The FDA utilizes the User Fee Programs to assess and collect fees to fulfill its mission of protecting the public health and accelerating innovation in the industry. The User Fee performance dashboards provide a concise, interactive, and visual presentation of the data in the legislatively-mandated Performance Reports to Congress. For more information about FDA-TRACK and what other centers across FDA are tracking, please visit our What's New page and the FDA-TRACK home page.   The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research  provides guidance, education and updates for regulated industry. Subscribe to CDER SBIA Email Updates Register for Upcoming Training View 2021 Recordings on YouTube Follow on LinkedIn Follow on Twitter This is an automated message delivery system. Replying to this message will not reach the CDER SBIA staff. If you have comments or questions, contact us at CDERSBIA@fda.hhs.gov or 1-866-405-5367 or (301) 796-6707.  SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA